Delivery Order SPE2DB22D3102-SPE2DB25FL2HW
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA). The $1,134.63 firm fixed-price delivery order is for the supply of 4,566,817,731 units of the drug Atomoxetine HCL 25 mg capsules. The contract has an ultimate completion date of January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Atomoxetine HCL 18 mg capsules (30-count units) with a contract value of $1,935.72. This non-set-aside, competitively awarded delivery order represents a firm fixed-price transaction with an ultimate completion date of August 25, 2025. The award is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Atomoxetine HCL 40 mg capsules. The firm-fixed-price contract, which does not have a set-aside designation, has a ceiling value of $1,891.58 and an ultimate completion date of September 30, 2024. AmerisourceBergen, through its Corporate Office Division, is a key contractor for providing a wide range of prescription medications,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 5, 2025, for the supply of Atomoxetine HCL 60 mg capsules (30-count units) with a ceiling value of $1,012.36. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract carries no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Atomoxetine HCL 25 mg capsules in quantities of 30 units, with a contract ceiling value of $2,326.72. This is a firm fixed price delivery order with an ultimate completion date of September 8, 2025, and was awarded on a non-set-aside, competitive basis. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,281,057 units of Atomoxetine HCl 60 mg capsules. The delivery order is a firm-fixed price contract with a ceiling value of $1,022.40 and a period of performance through October 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $455.94 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100mg Atomoxetine HCL capsules. The delivery order is for 30 capsules to be delivered to a location in Conshohocken, Pennsylvania within a one day period beginning on September 13, 2023. The Defense Logistics Agency Troop Support Medical supports the medical supply needs of the Department of...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $281,500 delivery order by the Defense Logistics Agency to supply 100mg capsules of atomoxetine hydrochloride. The firm fixed price contract calls for the delivery of 30 capsules to a facility in Conshohocken, Pennsylvania within a one day period beginning July 25, 2023. The Defense Logistics Agency routinely issues delivery orders against various pharmaceutical distribution vehicles to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,095.38 firm fixed-price delivery order is for the supply of 4,565,504,831 units of the prescription medication Atomoxetine HCL 60 mg capsules. The contract has an ultimate completion date of August 20, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Atomoxetine HCL 40 mg capsules in quantities of 30 units. This contract represents a non-set-aside, competitively awarded delivery order with firm fixed pricing and a ceiling value of $1,996.53. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 2, 2025. This delivery order is issued under AmerisourceBergen Drug...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2HWDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency valued at $1,453.90 for the supply of Atomoxetine HCL 10 mg capsules (30-count units). This award, issued on July 31, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, to be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.9 billion prime vendor agreement running through December 2026 that enables the pharmaceutical distributor to supply a broad range of medications and medical supplies to support military healthcare systems globally. As a major federal pharmaceutical vendor, AmerisourceBergen Drug Corp fulfills critical medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through this flexible contracting vehicle, with the Defense Logistics Agency planning to expand the Pharmaceutical Prime Vendor Global Program to include multiple regional contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/31/25 |